Katherine Cornish-Bowden Purchases 2,000 Shares of International Biotechnology (LON:IBT) Stock

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden purchased 2,000 shares of the stock in a transaction on Tuesday, May 13th. The shares were bought at an average cost of GBX 585 ($7.79) per share, for a total transaction of £11,700 ($15,570.93).

International Biotechnology Trading Down 1.1%

IBT stock opened at GBX 550 ($7.32) on Friday. The firm has a market capitalization of £197.57 million, a PE ratio of 5.25 and a beta of 0.21. International Biotechnology has a 1-year low of GBX 480 ($6.39) and a 1-year high of GBX 736 ($9.80). The business’s 50 day simple moving average is GBX 588.07 and its 200 day simple moving average is GBX 660.12.

International Biotechnology (LON:IBT) last posted its earnings results on Tuesday, May 13th. The company reported GBX (5.60) (($0.07)) earnings per share for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. As a group, sell-side analysts predict that International Biotechnology will post 0.9435943 EPS for the current fiscal year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.